Live feed06:45:00·1478dPRReleasevia QuantisnowMerck and Ridgeback Announce New Data For Investigational LAGEVRIO™ (molnupiravir) From Phase 3 MOVe-OUT StudyByQuantisnow·Wall Street's wire, on your screen.MRK· Merck & Company Inc.Health Care